Adar1-Capital-Management

AI_NATIVE detailed information: This accession holds the following tickers:[
  "JWN",
  "MRUS",
  "AKRO",
  "KNSA",
  "ASND",
  "EWTX",
  "CNTA",
  "NKTR",
  "INSM",
  "RVMD",
  "TIL",
  "ARGX",
  "AQN",
  "EXAS",
  "MDGL",
  "APLS",
  "ARWR",
  "PTCT",
  null,
  null,
  null,
  "IROH",
  null,
  null,
  null,
  null,
  null,
  null,
  "ABVX",
  null,
  "DVAX",
  "MREO",
  "RGNX",
  "RXRX",
  "SWTX",
  "RCKT",
  "ARVN",
  "ATXS",
  "TNGX",
  "GPCR",
  "SLN",
  "SVRA",
  "THRD",
  "TSHA",
  "ACHV",
  "NRIX",
  "STOK",
  "SMMT",
  "TECX",
  "MLYS",
  "KYMR",
  "PHAT",
  "NMRA",
  "KROS",
  "ADGM",
  "ABOS",
  "NGNE",
  "SAGE",
  "ALEC",
  "ALDX",
  "AVTX",
  "AMLX",
  "JANX",
  "AVR",
  "BIOA",
  "PHGE",
  "BOLT",
  "CLRB",
  null,
  null,
  "CTNM",
  "ESTA",
  "GERN",
  "SRRK",
  "FULC",
  "SYRE",
  "APGE",
  "ISRG",
  "ABUS",
  null,
  null,
  "KALA",
  "KRRO",
  "KALV",
  "LPTX",
  "LXEO",
  null,
  "MNPR",
  "NXTC",
  "OABI",
  "OVID",
  "OKUR",
  "RLYB",
  "PRQR",
  "QNCX",
  "PMVP",
  "RNXT",
  "SPRO",
  "SEPN",
  "STTK",
  "SGRY",
  "IOVA",
  null,
  null,
  null,
  null,
  "IKT",
  "TARA",
  "RZLT",
  "NVS",
  "TEVA",
  null,
  "ZYME",
  "ZURA",
  null,
  null,
  "OGN",
  "PFE",
  null,
  null,
  null,
  "REGN",
  null,
  null,
  "UPB",
  "RAPT",
  "PTGX",
  "PEPG",
  "AGIO",
  "AVXL",
  null,
  "SLDB",
  "TENX",
  "LYRA",
  "RYTM",
  "MLTX",
  "SLNO",
  "ACLX",
  null,
  "ETNB",
  "DYN",
  "ARDX",
  "CKPT",
  "SPRB",
  "TXMD",
  "GOSS",
  "SRPT",
  "NTRA",
  "WVE",
  "ROIV",
  null,
  null,
  "CNTB",
  "CNTX",
  "CDTX",
  "ELDN",
  "DCTH",
  null,
  "IMNM",
  "ITOS",
  "INZY",
  "KURA",
  "KZR",
  null,
  "VRNA",
  "VTYX",
  "VTGN",
  "VKTX",
  "VIR",
  "VRDN",
  "VYNE",
  "VYGR",
  "XENE",
  "XLO",
  "ZLAB",
  "XNCR",
  "ORKA",
  "BIIB",
  "BHVN",
  null,
  "IMVT",
  null,
  "PCVX",
  "BCRX",
  "BNTX",
  "BMRN",
  "BBIO",
  "CRGX",
  "CLDX",
  "CGON",
  "CLOV",
  "CRNX",
  "DAWN",
  "CTMX",
  "CYTK",
  "DNLI",
  "DNTH",
  "LLY"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 198
Total Value: 523731625
Accession Number: 0001940272-25-000003
Form Type: 13F-HR
CIK: adar1-capital-management
Manager Name: Adar1-Capital-Management

Data Enrichment

82% identified

163 identified35 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

198 positions • $523.7M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 9 of 10

Sort by:

G1933S101

Shares:47.4K

Value:$102.4K

% of Portfolio:0.0% ($102.4K/$523.7M)

CLOVER HEALTH INVESTMENTS, CORP. /DE

CLOV|18914F103

Shares:28.3K

Value:$101.6K

% of Portfolio:0.0% ($101.6K/$523.7M)

Bolt Biotherapeutics, Inc.

BOLT|097702104

Shares:245.0K

Value:$98.0K

% of Portfolio:0.0% ($98.0K/$523.7M)

Shattuck Labs, Inc.

STTK|82024L103

Shares:102.2K

Value:$97.1K

% of Portfolio:0.0% ($97.1K/$523.7M)

Upstream Bio, Inc.

UPB|91678A107

Shares:15.0K

Value:$91.8K

% of Portfolio:0.0% ($91.8K/$523.7M)

Avalo Therapeutics, Inc.

AVTX|05338F306

Shares:10.0K

Value:$80.1K

% of Portfolio:0.0% ($80.1K/$523.7M)

Inozyme Pharma, Inc.

INZY|45790W108

Shares:87.8K

Value:$79.9K

% of Portfolio:0.0% ($79.9K/$523.7M)

RECURSION PHARMACEUTICALS, INC.

RXRX|75629V104

Shares:15.0K

Value:$79.3K

% of Portfolio:0.0% ($79.3K/$523.7M)

BIOCRYST PHARMACEUTICALS INC

BCRX|09058V103

Shares:10.0K

Value:$75.0K

% of Portfolio:0.0% ($75.0K/$523.7M)

Lyra Therapeutics, Inc.

LYRA|55234L105

Shares:533.2K

Value:$67.3K

% of Portfolio:0.0% ($67.3K/$523.7M)

Phathom Pharmaceuticals, Inc.

PHAT|71722W107

Shares:10.1K

Value:$63.3K

% of Portfolio:0.0% ($63.3K/$523.7M)

Adagio Medical Holdings, Inc.

ADGM|00534B100

Shares:76.8K

Value:$61.8K

% of Portfolio:0.0% ($61.8K/$523.7M)

NextCure, Inc.

NXTC|65343E108

Shares:120.0K

Value:$57.6K

% of Portfolio:0.0% ($57.6K/$523.7M)

Tango Therapeutics, Inc.

TNGX|87583X109

Shares:41.3K

Value:$56.6K

% of Portfolio:0.0% ($56.6K/$523.7M)

Eledon Pharmaceuticals, Inc.

ELDN|28617K101

Shares:16.6K

Value:$56.3K

% of Portfolio:0.0% ($56.3K/$523.7M)

Silence Therapeutics plc

SLN|82686Q101

Shares:18.6K

Value:$52.6K

% of Portfolio:0.0% ($52.6K/$523.7M)

IOVANCE BIOTHERAPEUTICS, INC.

IOVA|462260100

Shares:15.7K

Value:$52.3K

% of Portfolio:0.0% ($52.3K/$523.7M)

NEKTAR THERAPEUTICS

NKTR|640268108

Shares:67.8K

Value:$46.1K

% of Portfolio:0.0% ($46.1K/$523.7M)

OnKure Therapeutics, Inc.

OKUR|68277Q105

Shares:10.0K

Value:$43.0K

% of Portfolio:0.0% ($43.0K/$523.7M)

Ovid Therapeutics Inc.

OVID|690469101

Shares:115.9K

Value:$36.1K

% of Portfolio:0.0% ($36.1K/$523.7M)

Instrument	Shares		Other Manager	Value	% of Portfolio
(cusipG1933S101)✕	47.4K	QoQ +2.37% (-1.1K) YoY NEW(+47.4K)	All Managers (Combined)	$102.4K	0.0% ($102.4K/$523.7M)	QoQ -21.86% (-$28.7K) YoY NEW(+$102.4K)
CLOVER HEALTH INVESTMENTS, CORP. /DE(CLOVcusip18914F103)	28.3K	QoQ +21.45% (+5.0K) YoY NEW(+28.3K)	All Managers (Combined)	$101.6K	0.0% ($101.6K/$523.7M)	QoQ +38.42% (+$28.2K) YoY NEW(+$101.6K)
Bolt Biotherapeutics, Inc.(BOLTcusip097702104)	245.0K	QoQ 0.00% (-0) YoY +4799.32% (+240.0K)	All Managers (Combined)	$98.0K	0.0% ($98.0K/$523.7M)	QoQ -25.24% (-$33.1K) YoY +1299.80% (+$91.0K)
Shattuck Labs, Inc.(STTKcusip82024L103)	102.2K	QoQ NEW(+102.2K) YoY NEW(+102.2K)	All Managers (Combined)	$97.1K	0.0% ($97.1K/$523.7M)	QoQ NEW(+$97.1K) YoY NEW(+$97.1K)
Upstream Bio, Inc.(UPBcusip91678A107)	15.0K	QoQ NEW(+15.0K) YoY NEW(+15.0K)	All Managers (Combined)	$91.8K	0.0% ($91.8K/$523.7M)	QoQ NEW(+$91.8K) YoY NEW(+$91.8K)
Avalo Therapeutics, Inc.(AVTXcusip05338F306)	10.0K	QoQ NEW(+10.0K) YoY +66.66% (-4.0K)	All Managers (Combined)	$80.1K	0.0% ($80.1K/$523.7M)	QoQ NEW(+$80.1K) YoY -38.62% (-$50.4K)
Inozyme Pharma, Inc.(INZYcusip45790W108)	87.8K	QoQ +15.07% (-11.5K) YoY NEW(+87.8K)	All Managers (Combined)	$79.9K	0.0% ($79.9K/$523.7M)	QoQ -62.19% (-$131.5K) YoY NEW(+$79.9K)
RECURSION PHARMACEUTICALS, INC.(RXRXcusip75629V104)	15.0K	QoQ 0.00% (-0) YoY NEW(+15.0K)	All Managers (Combined)	$79.3K	0.0% ($79.3K/$523.7M)	QoQ -21.74% (-$22.1K) YoY NEW(+$79.3K)
BIOCRYST PHARMACEUTICALS INC(BCRXcusip09058V103)	10.0K	QoQ -71.42% (-25.0K) YoY NEW(+10.0K)	All Managers (Combined)	$75.0K	0.0% ($75.0K/$523.7M)	QoQ -71.50% (-$188.2K) YoY NEW(+$75.0K)
Lyra Therapeutics, Inc.(LYRAcusip55234L105)	533.2K	QoQ 0.00% (-0) YoY NEW(+533.2K)	All Managers (Combined)	$67.3K	0.0% ($67.3K/$523.7M)	QoQ -38.80% (-$42.7K) YoY NEW(+$67.3K)
Phathom Pharmaceuticals, Inc.(PHATcusip71722W107)	10.1K	QoQ 0.00% (-0) YoY NEW(+10.1K)	All Managers (Combined)	$63.3K	0.0% ($63.3K/$523.7M)	QoQ -22.78% (-$18.7K) YoY NEW(+$63.3K)
Adagio Medical Holdings, Inc.(ADGMcusip00534B100)	76.8K	QoQ 0.00% (-0) YoY NEW(+76.8K)	All Managers (Combined)	$61.8K	0.0% ($61.8K/$523.7M)	QoQ -23.34% (-$18.8K) YoY NEW(+$61.8K)
NextCure, Inc.(NXTCcusip65343E108)	120.0K	QoQ 0.00% (-0) YoY +179.00% (-77.0K)	All Managers (Combined)	$57.6K	0.0% ($57.6K/$523.7M)	QoQ -37.70% (-$34.9K) YoY -39.90% (-$38.3K)
Tango Therapeutics, Inc.(TNGXcusip87583X109)	41.3K	QoQ NEW(+41.3K) YoY NEW(+41.3K)	All Managers (Combined)	$56.6K	0.0% ($56.6K/$523.7M)	QoQ NEW(+$56.6K) YoY NEW(+$56.6K)
Eledon Pharmaceuticals, Inc.(ELDNcusip28617K101)	16.6K	QoQ +3.75% (-600) YoY NEW(+16.6K)	All Managers (Combined)	$56.3K	0.0% ($56.3K/$523.7M)	QoQ -14.63% (-$9.6K) YoY NEW(+$56.3K)
Silence Therapeutics plc(SLNcusip82686Q101)	18.6K	QoQ +3.57% (-643) YoY -53.49% (-21.4K)	All Managers (Combined)	$52.6K	0.0% ($52.6K/$523.7M)	QoQ -57.54% (-$71.3K) YoY -93.92% (-$813.4K)
IOVANCE BIOTHERAPEUTICS, INC.(IOVAcusip462260100)	15.7K	QoQ 0.00% (-0) YoY +214.00% (-10.7K)	All Managers (Combined)	$52.3K	0.0% ($52.3K/$523.7M)	QoQ -55.00% (-$63.9K) YoY -29.44% (-$21.8K)
NEKTAR THERAPEUTICS(NKTRcusip640268108)	67.8K	QoQ 0.00% (-0) YoY NEW(+67.8K)	All Managers (Combined)	$46.1K	0.0% ($46.1K/$523.7M)	QoQ -26.88% (-$16.9K) YoY NEW(+$46.1K)
OnKure Therapeutics, Inc.(OKURcusip68277Q105)	10.0K	QoQ NEW(+10.0K) YoY NEW(+10.0K)	All Managers (Combined)	$43.0K	0.0% ($43.0K/$523.7M)	QoQ NEW(+$43.0K) YoY NEW(+$43.0K)
Ovid Therapeutics Inc.(OVIDcusip690469101)	115.9K	QoQ -11.23% (-14.7K) YoY +604.52% (-99.4K)	All Managers (Combined)	$36.1K	0.0% ($36.1K/$523.7M)	QoQ -70.34% (-$85.7K) YoY -27.95% (-$14.0K)